Raltegravir in Combination With Other Antiretroviral Agents for the Treatment of HIV Infection

Infection and Drug Resistance - New Zealand
doi 10.2147/idr.s9689
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Raltegravir With Optimized Background Therapy for Resistant HIV-1 Infection

New England Journal of Medicine
Medicine
2008English

HIV-associated Extracavitary Primary Effusion Lymphoma Successfully Treated With Antiretroviral Agents and CHOP Combination Chemotherapy

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
2017English

Improving Antiretroviral Therapy in Children With Hiv Infection

CHILDREN INFECTIONS
2018English

Modelling Multiple Dosing With Drug Holiday in Antiretroviral Treatment on HIV-1 Infection

Journal of Mathematical and Fundamental Sciences
Planetary SciencesGeneticsAstronomyMolecular BiologyBiochemistryMultidisciplinaryBiological SciencesMathematicsEarthMedicineAgriculturalChemistryPhysics
2017English

Antiretroviral Therapy in HIV Infection

Archives of Neurology
2004English

Ultrasonographic Measures of Cardiovascular Disease Risk in Antiretroviral Treatment-Naive Individuals With HIV Infection

AIDS
Infectious DiseasesAllergyImmunology
2013English

Raltegravir With Unboosted Atazanavir 300 Mg Twice Daily in Antiretroviral Treatment-Experienced Participants

Journal of the International Association of Physicians in AIDS Care
2009English

Nevirapine-Raltegravir Combination, a NRTI and PI/r Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-infected Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

New Antiretroviral Therapies for Pediatric HIV Infection

Journal of Pediatric Pharmacology and Therapeutics
Child HealthPediatricsPerinatologyPharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy